Skip to main content

Phase 3, 2-part Study to Eval Efficacy of Tenofovir Alafenamide vs Placebo Added to Failing Regimen Followed by Treatment with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Positive Antiretroviral Treatment-Experienced Adults

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Infectious Diseases

Awarded By

Gilead Sciences, Inc.

Start Date

November 1, 2013

End Date

October 31, 2016
 

Administered By

Medicine, Infectious Diseases

Awarded By

Gilead Sciences, Inc.

Start Date

November 1, 2013

End Date

October 31, 2016